CIK 0001540159 · Non-accelerated filer<br>Smaller reporting company
Edesa Biotech, Inc.
Sign in to watch- Ticker
- EDSA
- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- FY end
- Sep 30
- Incorporated
- British Columbia, Canada
- Entity type
- operating
- Phone
- (905) 475-1234
- Business address
- C/O FASKEN MARTINEAU DUMOULIN LLP, 333 BAY STREET, SUITE 2400, TORONTO, Ontario, Canada, M5H 2T6
- Former names
- Stellar Biotechnologies, Inc.
- 4/A Grant or award Director acquired 140,625 shares (grant or award)
- 4/A Grant or award President acquired 1,827 shares (grant or award)
- 4/A Grant or award Director acquired 2,436 shares (grant or award)
- 4/A Grant or award Director acquired 8,524 shares (grant or award)
- 4 Grant or award Chief Executive Officer acquired 9,255 shares (grant or award)
- 4 Grant or award Director acquired 1,218 shares (grant or award)
- 4 Grant or award Chief Financial Officer acquired 1,218 shares (grant or award)
- 4 Grant or award Director acquired 2,436 shares (grant or award)
- 4 Open-market buy Director bought 140,625 shares at $3.20 ($450,000)
- 4 Open-market buy Director bought 2,436 shares at $4.11 ($10,012)
- 4 Open-market buy Director bought 8,524 shares at $4.11 ($35,034)
- 4 Open-market buy President bought 1,827 shares at $4.11 ($7,509)
- 8-K Event Other events
- 424B5 Offering Prospectus
- 8-K Event Material agreement · Unregistered share sale · Other events
- 10-KT Report 10-KT
- 8-K Event Results of operations
- DEF 14C Other DEF 14C
- 8-K Event Executive or director change · Shareholder vote results
- 4 Open-market sale Director sold 1,809 shares at $5.72 ($10,345)
Page 20 of 38 · 753 filings